Invivo Anti-Human EGFR Recombi

EGFR单抗与肿瘤治疗进展

研究中[8]。（3）MAB528与MAB225MAB528、MAB225是针对EGFR胞外区的鼠源性抗体[9]。它们与EGF、TGFα和EGFR有相似的亲和力，竞争性与EGFR配体结合区结合，减低酪氨酸激酶的活化。能明显抑制培养细胞及裸鼠肿瘤移植物的增殖。（4）其它EMD55900[10]、 ICR62[11]是鼠源性单克隆抗体。在头颈部上皮性肿瘤体外试验显示了抗增生活性。CIBCNSH3[11]也是针对过表达EGFR肿瘤的单克隆抗体。体外实验CIBCNSH3与过表达EGFR细胞共育，发现98%细胞

Recombinant Immunotoxins in the Treatment of Cancer

Recombinant immunotoxins are chimeric proteins composed of the Fv portion of a monoclonal antibody (MAb) fused to a portion of a toxin. The Fv replaces the cell-binding domain of the toxin and directs the toxin to cancer cells that express

Expression of Recombinant Antibodies in Mammalian Cell Lines

, multidomain molecules such as full-length MAbs or complex recombinant antibody fragments, eukaryotic systems such as mammalian or yeast expression have been utilized. Currently, nine USFDA-licensed Mabs for in vivo human use have been expressed from mammalian